Clinical Pharmacology

Selected news for the healthcare topic - Clinical Pharmacology, collected since 10/2017. There are 8.9K items in the archive. This healthcare topic shares news with Food and Drug Administration, Heart Disease, COVID-19, Clinical Research, Pfizer and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/7/2022 Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities PR Newswire ... highly complex early phase trials including pain modeling, qEEG/EEG, respiratory depression, and alcohol interaction, among others.Glen Apseloff , MD, Founder and Principal Investigator, has over 30 years of experience designing and executing complex clinical pharmacology studies. As the Director of Clinical Pharmacology in the Department of Pharmacology at Ohio State University (OSU) College of Medicine for more than a decade, Dr. Apseloff was responsible for all phase 1 clinical ...
5/24/2022 Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting | Business Wire Business Wire ... and include assessments of safety, tolerability, efficacy, and the relationships between dosing regimen, consortium strain colonization, and restoration of a patient’s resident microbial community. These analyses further deepen Vedanta’s understanding of the clinical pharmacology and potential benefits of defined bacterial consortia and help inform future clinical research. This body of data builds on published analyses from earlier clinical work that identified key factors that drive colonization of Vedanta ...
5/24/2022 PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting Business Wire ... and include assessments of safety, tolerability, efficacy, and the relationships between dosing regimen, consortium strain colonization, and restoration of a patient’s resident microbial community. These analyses further deepen Vedanta’s understanding of the clinical pharmacology and potential benefits of defined bacterial consortia, and help inform future clinical research. This body of data builds on published analyses from earlier clinical work that identified key factors that drive colonization of Vedanta ...
5/24/2022 Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting Business Wire ... and include assessments of safety, tolerability, efficacy, and the relationships between dosing regimen, consortium strain colonization, and restoration of a patient’s resident microbial community. These analyses further deepen Vedanta’s understanding of the clinical pharmacology and potential benefits of defined bacterial consortia and help inform future clinical research. This body of data builds on published analyses from earlier clinical work that identified key factors that drive colonization of Vedanta ...
5/24/2022 PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting | Business Wire Business Wire ... and include assessments of safety, tolerability, efficacy, and the relationships between dosing regimen, consortium strain colonization, and restoration of a patient’s resident microbial community. These analyses further deepen Vedanta’s understanding of the clinical pharmacology and potential benefits of defined bacterial consortia, and help inform future clinical research. This body of data builds on published analyses from earlier clinical work that identified key factors that drive colonization of Vedanta ...
5/19/2022 Clinical Pharmacology Consultant monster.com We have an excellent job opportunity available as a Clinical Pharmacology Consultant. If you are looking for a job that impacts others, then this is the job for you!This role is expected to last 6-12 months.Requirements of the Clinical Pharmacology Consultant:- At least 10 years of cross-functional program leadership experience- In-depth clinical pharmacology experience, able to act as a SME- Ability to evaluate and advise on ...
5/18/2022 Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer | Business Wire Business Wire ... degree from the University of Chicago Pritzker School of Medicine, as well as Master's and Bachelor's degrees in Biochemistry from the University of Rochester. She completed a residency in Internal Medicine and fellowships in Clinical Pharmacology and Pulmonary and Critical Care Medicine at the University of Chicago Hospitals.“We are proud to welcome Dr. Cheryl Renz as a member of the Pregistry team. She will help ensure that Pregistry’s ...
5/18/2022 EpiEndo: Successful Completion of Phase I Study for Lead Asset EP395 | Business Wire Business Wire ... development for chronic respiratory diseases, focusing on enhancing the integrity of the epithelial cell layer in the lung to reduce disease-causing inflammation.The study’s Principal Investigator was Professor Dave Singh, professor of clinical pharmacology and respiratory medicine at the University of Manchester. It was designed to assess the safety and tolerability of ascending single and multiple (up to 28 days) doses of the Barriolide™ EP395, administered as ...
5/4/2022 Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies fda.gov ... written comments should be identified with this document's docket number: FDA-2022-D-0113- Docket Number:-- Issued by:- Guidance Issuing OfficeCenter for Drug Evaluation and ResearchThis guidance describes the FDA’s recommendations regarding clinical pharmacology considerations for conducting human radiolabeled mass balance studies of investigational drugs, including: (1) deciding whether and when to conduct the study, (2) designing the study, and (3) reporting results. This guidance does not cover ...
5/3/2022 Dr. Nidal Huniti joins A2PG as President PR Newswire ... he spent nine years with AstraZeneca, where he rose to the role of Executive Director and Head of US Oncology and Data Programming & Operations, before joining Regeneron as Executive Director and Head of Quantitative Clinical Pharmacology for two years."Joining A2PG and Amador is a wonderful, exciting opportunity," Dr. Huniti said. "In my career, I've learned that the most important things in our industry are hard work and innovation, and ...
5/2/2022 Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD) | Business Wire Business Wire ... 2022.Data from the completed studies of zuranolone in the LANDSCAPE and NEST clinical development programs, including data from the ongoing open-label SHORELINE Study in MDD, as well as data from the completed clinical pharmacology studies, will comprise the full submission package. The rolling submission process allows completed sections of an NDA to be submitted to the FDA for review on an ongoing basis.“There are millions of people ...
5/2/2022 Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD) Business Wire ... en/Data from the completed studies of zuranolone in the LANDSCAPE and NEST clinical development programs, including data from the ongoing open-label SHORELINE Study in MDD, as well as data from the completed clinical pharmacology studies, will comprise the full submission package. The rolling submission process allows completed sections of an NDA to be submitted to the FDA for review on an ongoing basis.“There are millions of people ...
4/27/2022 Viance Expands R&D Department PR Newswire ... Dr. Ibrahim earned his doctorate in Philosophy (PhD) in Polymer Chemistry from the University of North Carolina at Chapel Hill . Dr. Ibrahim's chemistry formulation experience includes development work with Syngenta and Sherwin Williams , with clinical pharmacology experience with Nuventra.Dr. Rufai Ibrahim, Sr. Formulation Chemist for Viance, LLC Viance expands R&D Department, hiring Dr. Rufai Ibrahim as Sr. Formulation Chemist.Tweet this Dr. Kevin Archer , Director of Research and ...
4/27/2022 Viance Expands R&D Department PR Newswire ... Dr. Ibrahim earned his doctorate in Philosophy (PhD) in Polymer Chemistry from the University of North Carolina at Chapel Hill . Dr. Ibrahim's chemistry formulation experience includes development work with Syngenta and Sherwin Williams , with clinical pharmacology experience with Nuventra.Dr. Rufai Ibrahim, Sr. Formulation Chemist for Viance, LLC Viance expands R&D Department, hiring Dr. Rufai Ibrahim as Sr. Formulation Chemist.Tweet this Dr. Kevin Archer , Director of Research and ...
4/14/2022 2022 Annual Meeting of the American College of Clinical Pharmacology® - The Premier Clinical Pharmacology Educational & Scientific Meeting PR Newswire Transforming Global Health through Clinical PharmacologyASHBURN, Va. The American College of Clinical Pharmacology® (ACCP) is pleased to announce the 2022 ACCP Annual Meeting ( 2022ACCP) will be held September 25 – 27, 2022. After two years of virtual events, we are honored to be the first clinical pharmacology-focused meeting that is face-to-face with colleagues. We encourage you to join us for this outstanding educational and scientific ...
4/14/2022 2022 Annual Meeting of the American College of Clinical Pharmacology® - The Premier Clinical Pharmacology Educational & Scientific Meeting vporoom.com Transforming Global Health through Clinical PharmacologyASHBURN, Va., April 14, 2022 / PRNewswire / -- The American College of Clinical Pharmacology® (ACCP) is pleased to announce the 2022 ACCP Annual Meeting ( 2022ACCP) will be held September 25 – 27, 2022. After two years of virtual events, we are honored to be the first clinical pharmacology-focused meeting that is face-to-face with colleagues. We encourage you to join us for this ...
4/8/2022 Indivior Publishes Modeling Data Showing Buprenorphine May Mitigate Fentanyl-Induced Respiratory Depression in Chronic Opioid Users PR Newswire ... at the level of the mu-opioid receptor (MOR) on minute ventilation under elevated carbon dioxide levels in opioid-naïve volunteers and chronic opioid users. 1 Data used for modeling were from a clinical pharmacology study recently published in PLOS ONE. 2 The main objective of the modeling was to characterize the effects of escalating intravenous fentanyl doses (0.25-0.70 mg/70 kg range in chronic opioid users) on respiratory ...
4/7/2022 Grants Manager (Remote) - Clinical Pharmacology - USA-TN-Nashville granted.com Grants Manager (Remote) - Clinical PharmacologyGRANTS MANAGER - CLINICAL PHARMACOLOGYJOB SUMMARY:Assist faculty in preparing and assembling grants proposals/contracts in compliance with sponsor, University, and federal guidelines and deadlines. Interact with other departments and agencies to facilitate the development, submission, and administration of grant proposals. Independently manage budget responsibilities for grants. Monitor terms and agreements of grant awards for compliance.KEY RESPONSIBILITIES:Assist faculty in preparing and assembling grants ...
4/7/2022 Mitotane (Clinical Pharmacology) ptmasterguide.com In this article, we will discuss Mitotane (Clinical Pharmacology). So, let’s get started.Clinical PharmacologyMitotane can best be described as an adrenal cytotoxic agent, although it can cause adrenal inhibition, apparently without cellular destruction. Its biochemical mechanism of action is unknown. Data are available to suggest that the drug modifies the peripheral metabolism of steroids as well as directly suppressing the adrenal cortex. The administration of Mitotane alters ...
4/6/2022 CellCentric Strengthens Leadership Team PR Newswire Kris Frese formerly Co-Lead at the Cancer Biomarker Centre Preclinical Pharmacology Team at Cancer Research UK, joins as Director of Cancer Biology Andrew Hughes , Chief Development Adviser, who has led over 50 oncology R&D programmes at AstraZeneca, joins the Board CAMBRIDGE, England , April 6, CellCentric, a clinical stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, today announces the appointments of Kris Frese ...